Clinical Trials In Maryland

Discover hundreds of clinical trials in Maryland.
Search clinical trials in Maryland by city, condition or phase.

e.g. Respiratory Diseases

Maryland•Healthy volunteers: No

Filter results

Results: 2,217

Genomic Services Research Program

Recruiting

Sponsor:

National Human Genome Research Institute (NHGRI)

Location:

Bethesda

Code:

NCT02595957

Conditions

Colon Cancer

Breast Cancer

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Baltimore, Palo Alto, Gainesville, Seattle

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Recruiting

Phase 1

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT03745326

Conditions

Gastrointestinal Cancer

Pancreatic Cancer

Gastric Cancer

Colon Cancer

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Fludarabine

Aldesleukin

anti-KRAS G12D mTCR PBL

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Bethesda, Ann Arbor

Code:

NCT00246857

Conditions

Primary Immune Deficiency

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Recruiting

Phase 1

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT02203526

Conditions

Primary Central Nervous System Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Isavuconazole

TEDDI

Rituximab

Cytarabine

TEDD

e.g. Respiratory Diseases

Maryland•Healthy volunteers: No

Filter results

Results: 2,217

Genomic Services Research Program

Recruiting

Sponsor:

National Human Genome Research Institute (NHGRI)

Location:

Bethesda

Code:

NCT02595957

Conditions

Colon Cancer

Breast Cancer

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Baltimore, Palo Alto, Gainesville, Seattle

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Recruiting

Phase 1

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT03745326

Conditions

Gastrointestinal Cancer

Pancreatic Cancer

Gastric Cancer

Colon Cancer

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Fludarabine

Aldesleukin

anti-KRAS G12D mTCR PBL

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Bethesda, Ann Arbor

Code:

NCT00246857

Conditions

Primary Immune Deficiency

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Recruiting

Phase 1

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT02203526

Conditions

Primary Central Nervous System Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Isavuconazole

TEDDI

Rituximab

Cytarabine

TEDD